BIO-B
Bio-Rad Laboratories, Inc.
NYSE · Healthcare · Medical - Devices · US
$381.37
+4.46%Leverage
- Debt / equity
- 0.17x
- Net debt / equity
- 0.10x
- Debt / assets
- 0.12x
- Debt / EBITDA
- 2.25x
- Net debt / EBITDA
- 1.28x
Liquidity & coverage
- Current ratio
- 3.14x
- Quick ratio
- 2.33x
- Cash ratio
- 1.68x
- Interest coverage
- 6.40x
- EBITDA / interest
- 14.57x
- Working capital
- $2.1B
Cash & dividend
- FCF / debt
- 0.29x
- Cash flow / debt
- 0.41x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026